These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Factors associated with drug adherence and blood pressure control in patients with hypertension. Morris AB; Li J; Kroenke K; Bruner-England TE; Young JM; Murray MD Pharmacotherapy; 2006 Apr; 26(4):483-92. PubMed ID: 16553506 [TBL] [Abstract][Full Text] [Related]
27. Compliance with antihypertensive therapy: raising the bar of expectations. Rudd P Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995 [TBL] [Abstract][Full Text] [Related]
28. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. Ohene Buabeng K; Matowe L; Plange-Rhule J J Pharm Pharm Sci; 2004 Nov; 7(3):350-2. PubMed ID: 15576016 [TBL] [Abstract][Full Text] [Related]
29. [The influence of socio-economic factors on the compliance of patients with treatment of hypertonic disease]. Serov VA; Gorbunov VI Klin Med (Mosk); 2007; 85(3):65-8. PubMed ID: 17523410 [TBL] [Abstract][Full Text] [Related]
30. [Use of antihypertensive drugs in Spain (1995-2001)]. García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428 [TBL] [Abstract][Full Text] [Related]
31. Factors related to non-compliance with antihypertensive drug therapy. Jokisalo E; Kumpusalo E; Enlund H; Halonen P; Takala J J Hum Hypertens; 2002 Aug; 16(8):577-83. PubMed ID: 12149664 [TBL] [Abstract][Full Text] [Related]
33. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of compliance among patients with hypertension. Patton K; Meyers J; Lewis BE Am J Manag Care; 1997 Nov; 3(11):1693-8. PubMed ID: 10178467 [TBL] [Abstract][Full Text] [Related]
35. Patient compliance with anti-hypertensive drug therapy. McMillan E Nursing (Lond); 1984 Jun; 2(26):761-4. PubMed ID: 6564420 [No Abstract] [Full Text] [Related]
36. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
37. [Validity of four indirect methods which evaluate therapeutic compliance for arterial hypertension]. Gil VF; Belda J; Muñoz C; Martínez JL; Soriano JE; Merino J Rev Clin Esp; 1993 Nov; 193(7):363-7. PubMed ID: 8290755 [TBL] [Abstract][Full Text] [Related]
38. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487 [TBL] [Abstract][Full Text] [Related]
39. 'Why don't you do as I tell you?' Compliance and antihypertensive regimens. Hansson L Int J Clin Pract; 2002 Apr; 56(3):191-6. PubMed ID: 12018825 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005]. Márquez Contreras E; Gil Guillén V; Casado Martínez JJ; Martel Claros N; De la Figuera von Wichmann M; Martín de Pablos JL; Atienza Martín F; Gros García T; Espinosa García J Aten Primaria; 2006 Oct; 38(6):325-32. PubMed ID: 17173796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]